Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
Polycaprolactone HA Injections
Ingredient: Polycaprolactone 10%, Cross linked hyaluronic acid 24mg/ml
Specification: 1ml
Package: Single package
Application Area: Used for nose, jaw, lacrimal groove, temple, outer contour and other subcutaneous deep or shallow injection.
Product Introduction：
PCL HA injections are an innovative hybrid filler that merges two biocompatible and biodegradable materials: hyaluronic acid, renowned for its hydrating and plumping properties, and polycaprolactone, a synthetic polymer long used in medical sutures. While HA delivers immediate volumization and smoothness to the treated area, PCL microspheres act as a scaffold that gradually stimulates the body's own collagen production over several months.
This dual action creates a unique effect: instant improvement in fine lines and facial contours, followed by progressive and natural skin rejuvenation as new collagen forms.
Product Display：
Product Details:
Type | PCL-HA Filler |
Ingredient | Polycaprolactone 10%, Cross linked hyaluronic acid 24mg/ml |
Specification | 1ml |
Effect area | The deep dermis, superficial subcutaneous and deep layers were filled by injection |
Application area | Used for nose, jaw, lacrimal groove, temple, outer contour and other subcutaneous deep or shallow injection |
How to choose | Moderate to severe naso-lip wrinkles |
Package | Single package |
Storage | Cool, dry environment |
Recommended | 1-2 pc/time |
Recommended interval | 12 months |
Lasting time | 12 months |
Microsphere size | The median particle size was 32±6μm, and more than 95% of the microspheres were between 25 and 50μm |
Product Package:
Customer Feedback：
Clinical studies and real-world use have shown that PCL HA injections offer several key advantages compared to traditional HA fillers:
Extended Longevity: Thanks to the collagen-stimulating effect of PCL, results can last up to 18–24 months, significantly longer than the typical 6–12 months of standard HA fillers.
Natural Look and Feel: The slow, controlled stimulation of collagen helps maintain natural facial expressions and avoids the "overfilled" appearance.
Biocompatibility and Safety: Both HA and PCL have well-documented safety profiles in medical applications, reducing the risk of adverse reactions.
Development Process:
Market Impact:
The introduction of PCL HA injections is reshaping the global filler market, estimated to exceed USD 8 billion by 2027. Several medical device companies have launched or are preparing to launch PCL HA products, driven by growing demand from both practitioners and patients for longer-lasting, minimally invasive treatments.
"The market trend is clearly moving toward combination fillers that offer both immediate correction and long-term regeneration," notes Emily Chen, an analyst specializing in aesthetic medicine at Global Medical Insights. "PCL HA injections are at the forefront of this transformation."
